1. Home
  2. AX vs SRRK Comparison

AX vs SRRK Comparison

Compare AX & SRRK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AX
  • SRRK
  • Stock Information
  • Founded
  • AX 1999
  • SRRK 2012
  • Country
  • AX United States
  • SRRK United States
  • Employees
  • AX N/A
  • SRRK N/A
  • Industry
  • AX Savings Institutions
  • SRRK Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • AX Finance
  • SRRK Health Care
  • Exchange
  • AX Nasdaq
  • SRRK Nasdaq
  • Market Cap
  • AX 3.5B
  • SRRK 3.1B
  • IPO Year
  • AX 2005
  • SRRK 2018
  • Fundamental
  • Price
  • AX $68.76
  • SRRK $30.67
  • Analyst Decision
  • AX Buy
  • SRRK Strong Buy
  • Analyst Count
  • AX 6
  • SRRK 6
  • Target Price
  • AX $81.50
  • SRRK $42.17
  • AVG Volume (30 Days)
  • AX 347.6K
  • SRRK 1.3M
  • Earning Date
  • AX 04-30-2025
  • SRRK 05-14-2025
  • Dividend Yield
  • AX N/A
  • SRRK N/A
  • EPS Growth
  • AX 0.28
  • SRRK N/A
  • EPS
  • AX 7.33
  • SRRK N/A
  • Revenue
  • AX $1,181,567,000.00
  • SRRK N/A
  • Revenue This Year
  • AX $21.13
  • SRRK N/A
  • Revenue Next Year
  • AX $5.22
  • SRRK $601.05
  • P/E Ratio
  • AX $9.41
  • SRRK N/A
  • Revenue Growth
  • AX 17.72
  • SRRK N/A
  • 52 Week Low
  • AX $44.10
  • SRRK $6.76
  • 52 Week High
  • AX $88.46
  • SRRK $46.98
  • Technical
  • Relative Strength Index (RSI)
  • AX 66.35
  • SRRK 47.15
  • Support Level
  • AX $66.26
  • SRRK $28.76
  • Resistance Level
  • AX $69.83
  • SRRK $33.48
  • Average True Range (ATR)
  • AX 1.93
  • SRRK 1.71
  • MACD
  • AX 0.82
  • SRRK -0.04
  • Stochastic Oscillator
  • AX 89.92
  • SRRK 32.60

About AX Axos Financial Inc.

Axos Financial Inc is a bank holding company that operates through its bank subsidiary, BofI Federal Bank, a nationwide bank that provides financing for single and multifamily residential properties, small to medium-size businesses in certain sectors, and selected specialty finance receivables. Its operating segments are banking business segment and securities business segment . The bank distributed its products through a wide range of retail distribution channels, including only banking brands, affinity groups, and sales teams, among others. The majority of the bank's mortgage exposure is titled toward the state of California, particularly its southern region. Net interest income is a majority of the bank's revenue.

About SRRK Scholar Rock Holding Corporation

Scholar Rock Holding Corp is a late-stage biopharmaceutical company focused on discovering, developing, and delivering innovative medicines for treating serious diseases in which signaling by protein growth factors plays a fundamental role. Its pipeline includes Neuromuscular and Obesity, Immuno-oncology, Fibrotic Disease, and Hematology. The group operates and manages its business as a single segment to assess performance and make operating decisions.

Share on Social Networks: